ATLANTA — Axion BioSystems vigorously refutes a recent filing by Agilent Technologies, Inc. (NYSE: A) claiming patent infringement and false advertising. As a recognized biotechnology innovator and owner of numerous patents over 14 years, Axion BioSystems expects its competitors to respect its intellectual property rights, just as Axion respects the intellectual property rights of its […]

We are excited to inform you that eralytics has been granted the patent US 11,493,417 B2 for the automated bubble detection and bubble quantification technology FillingProofTM . When measuring a liquid’s density, the U-tube’s vertical orientation minimizes the likelihood of air bubbles becoming trapped in the density cell. To ensure bubble-free filling, eralytics has developed Filling ProofTM.  This technology is […]

IRMO, S.C.  — Integrated Micro-Chromatography Systems, Inc. (IMCS), a leader in recombinant enzymes and micro-chromatography technologies, was awarded U.S. Patent No. 11,421,210 by the United States Patent Office. The patent, entitled “Chimeric and other variant beta-glucuronidase enzymes with enhanced properties,” is a new addition to their existing patents based on proprietary enzyme engineering technology. The […]

Halifax, Nova Scotia – Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) (“Sixth Wave”, “SIXW” or the “Company”) is pleased to announce that its patent pending Accelerated Molecularly Imprinted Polymer (“AMIPs™”) technology has expanded its library of detectable pathogens, such as E.coli, to include bacteria for Salmonella, Listeria, and Sarcina. Sixth Wave has integrated new bacteria-imprinted […]

Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit SAN DIEGO, Calif. — Executive Chairman and former CEO of Maravai LifeSciences, Inc. (NASDAQ: MRVI) Carl Hull, has been reinstated as CEO of the company on an interim basis. Three subsidiaries of Danaher Corporation, two of which previously employed recently-appointed Maravai CEO William “Trey” […]

– New function provides better information for data analysis and cancer diagnostics Nasdaq First North-listed Qlucore, whose software creates the conditions for faster, more precise, better cancer diagnostics and helps researchers with data analysis, has received a patent in Europe. This is for a new feature which generates robust analysis answers, even in the presence […]

Bio-Techne enforces intellectual property for gold standard RNAscope® ISH technology in spatial biology and clinical applications. MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced that it has taken legal action in the United Kingdom to halt the infringement of its patented […]

SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN), today received a decision from the European Commission prohibiting the company’s acquisition of GRAIL. The company is reviewing the Commission’s order and intends to appeal the decision. The EC decision follows last week’s ruling by US Federal Trade Commission judge in favor of Illumina’s acquisition of GRAIL. “We are disappointed with […]

WASHINGTON — Illumina, Inc. (NASDAQ:ILMN), today received a favorable decision from the Administrative Law Judge (ALJ) presiding over the Federal Trade Commission’s (FTC) challenge of the GRAIL acquisition. In the decision, the ALJ ruled for Illumina and rejected the FTC’s position that the deal would adversely affect competition in a putative market for multi-cancer early detection […]

Carlsbad CA and Research Triangle Park NC — CUT&Tag is a targeted transposition technique that allows high-resolution genomic mapping of histone modifications and chromatin- associated proteins through the precise insertion of DNA sequences into the genome using the Tn5 transposase enzyme. EpiCypher and Active Motif each own or control patents covering complementary aspects of targeted […]